ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 2 of 45
Up
УЖМБС 2018, 3(3): 12–15
https://doi.org/10.26693/jmbs03.03.012
Experimental Medicine and Morphology

Dynamics of Ventricular Wall and Interventricular Septum Thickness of Rat’s Heart in the Early Postnatal Period in Normal Conditions and after Intranatal Injection of Dexamethasone

Hryhorieva O. A., Cherniavskyi A. V.
Abstract

A significant part of cardiovascular system diseases in children is occupied by conditions and functional disorders associated with dysplasia of the heart connective tissue, which is caused by a number of factors, one of which is the adverse effect of various factors on the fetus in the antenatal period of development. The synthesized glucocorticosteroid dexamethasone is administered to pregnant women in the third trimester from risk of preterm delivery, to improve the surfactant system maturation in the fetus, to reduce the incidence of respiratory distress syndrome in newborns. The safety of using synthetic glucocorticoids in pregnant women is the subject of active discussions due to possible adverse effects of dexamethasone on the development of the fetus and, in particular, on the heart of the future child. The purpose of this research is to study the dynamics of the ventricles walls thickness and interventricular septum of the rats’ heart in the early postnatal period in normal conditions and after intranatal injection of dexamethasone. Materials and methods. Three groups of rats were examined in the research: the first one included intact animals; the second was comprised of experimental animals, who were injected by dexametazone by intrauterine, transcutaneous approach after conducting a median laparotomy of pregnant rat at the 17th day of pregnancy; the third group was formed by control animals, who were injected by saline solution in equal volume, by the same way, at the same day. Rats’ hearts were analyzed from birth up to the 45th day of life. Morphometric and statistic methods have been used during the research. Results and discussion. It was defined that after intrauterine fetal exposure of dexamethasone in newborns and on the 5th day after birth thickness of the right ventricle wall was significantly higher than in saline control group, due to possible premature cardiomyocytes maturation. This tendency lasted for the first two weeks, after that the differences equalized, and at the 45th day of experiment it became even thinner than in control group. This fact may be caused by decreasing of the cardiomyocytes’ proliferative activity and, as a consequence, by decreasing of their population. The thickness of the left ventricular wall was significantly higher during the first and the third day in experimental animals in comparison with those injected with the saline, and from the 5th day it became smaller. This tendency continued until the 45th day after birth, when these differences equalized. A similar situation was observed in the dynamics of the thickness of the interventricular septum: in newborn animals and on the 3rd day after birth, the septum was thicker in the experimental group compared with the control, where it decreased until the 45th day. Conclusions. The intrauterine fetal administration of dexamethasone leads to thickening of the right and left ventricles walls and interventricular septum in newborn rats. The tendency to increase during the first week and their thinning by the end of the first month was observed. This may be caused by the decreasing of the proliferative activity of cardiomyocytes and consequential decreasing of their population.

Keywords: morphogenesis, heart, intrauterine fetal exposure, dexamethasone

Full text: PDF (Ukr) 185K

References
  1. Galaktionova MYu, Kobeleva EA, Mironova OI. Osobennosti tsentralnoy gemodinamiki detey s sindromom displazii soedinitelnoy tkani serdtsa. Pediatricheskie aspekty displazii soedinitelnoy tkani. Dostizheniya i perspektivy: Rossiyskiy sbornik nauchnykh trudov s mezhdunarodnym uchastiem. 2013; 3: 225-34. [Russian]
  2. Melnichuk LV. Problemni pitannya diagnostiki ta likuvannya vrodzhenikh vad u ditey. Klinichna anatomiya ta operativna khirurgiya. 2015; 14 (4): 26-9. [Ukrainian]
  3. Shaytarova AV, Khramova EB, Suplotova LA. Diskussionnye voprosy vliyaniya glyukokortikoidnoy terapii beremennykh na zdorove detey. Voprosy sovremennoy pediatrii. 2011; 10 (2): 82-5. [Russian]
  4. Rog-Zielinska EA, Richardson RV, Denvir MA, Chapman KE. Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming. J Mol Endocrinol. 2014 Apr; 52 (2): 125-35. https://www.ncbi.nlm.nih.gov/pubmed/24299741. https://doi.org/10.1530/JME-13-0204
  5. Maresha S. Gay, Chiranjib Dasgupta, Yong Li, Angela Kanna, Lubo Zhang Dexamethasone induces cardiomyocyte terminal differentiation via epigenetic repression of cyclin d2 gene. J Pharmacol Exp Ther. 2016 Aug; 358: 190-8. https://doi.org/10.1124/jpet.116.234104
  6. Maresha S. Gay, Yong Li, Fuxia Xiong, Thant Lin, Lubo Zhang. Dexamethasone treatment of newborn rats decreases cardiomyocyte endowment in the developing heart through epigenetic modifications. PLoS ONE. 2015 Apr; 10 (4): e0125033. https://doi.org/10.1371/journal.pone.0125033